___________________________________________

Return to Spring Meeting Page

 

Return to MetroFlow Home Page

 

Malignancies: What Flow Cytometry Can Tell Us

___________________________________________

   

Program

 

08:30 - 09:15    REGISTRATION AND BREAKFAST

 

09:15 - 09:30    WELCOME AND INTRODUCTION - Peter Lopez

 

09:30 - 10:30    Fred Preffer, PhD.  Massachusetts General Hospital.  

“Flow Cytometry and Diagnostic Hematopathology;

Somethings Old and Somethings New”

 

10:30 - 10:45    COFFEE BREAK

 

10:45 - 11:45    Sandra Demaria, MD.  NYU

Irradiated Tumors Attract Effector T-cells”

 

11:45 - 12:45    Teri Oldaker, BA, CLS.  Independent Health Care Consultant.  

2006 Bethesda International Consensus On Flow Cytometric

Immunophenotyping of Hematolymphoid Neoplasms

 

12:45 - 01:45    LUNCH

 

01:45 - 02:45    Elizabeth Raveche, PhD. UMDNJ

Using Flow Cytometry to Evaluate Monoclonal B  Lypmhocytosis (MBL)

in Familial  CLL in humans and the effects of  novel treatment in the NZB

murine model  CLL using lentiviral microRNA miR-15 gene delivery. "

 

02:45 - 03:45    Jeffrey Schrager, MD.  Genzyme Genetics.  

Clinical Applications of Flow Cytometric Immunophenotyping”

 

03:45 - 04:00    AFTERNOON BREAK

 

04:00 - 05:00    George Miller, MD.  NYU  

The Role of Resident Hepatic Myeloid Derived Suppressor Cells in Enabling

Liver Metastases from Gastrointestinal Cancers

 

 

 

 

www.metroflow.org